.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2015 for a tremendous $43 b...
.On the heels of a phase 3 succeed that fell short to wow real estate investors, Ironwood Pharmaceut...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...
.Invite to today's Chutes & Ladders, our summary of significant management hirings, shootings as ...
.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer calle...
.AbbVie has come back to the source of its antipsychotic giant Vraylar looking for one more smash hi...
.GenSight Biologics is weeks away from running out of cash. Once again. The biotech only has enough ...
.Monopar Therapies is actually bouncing back a medication coming from the dump of AstraZeneca's rare...
.Along with brand new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group...
.After developing a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is back for eve...